Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Jill Johnson

Concepts (52)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Drug Costs
3
2019
39
0.730
Why?
Managed Care Programs
1
2019
38
0.630
Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2019
21
0.630
Why?
Health Benefit Plans, Employee
3
2019
15
0.580
Why?
Hypoglycemic Agents
1
2019
174
0.560
Why?
Insurance, Pharmaceutical Services
2
2019
24
0.510
Why?
Diabetes Mellitus, Type 2
1
2019
515
0.410
Why?
Sulfonamides
1
2014
125
0.410
Why?
Pyrimidines
1
2014
187
0.400
Why?
Cost Sharing
2
2011
16
0.380
Why?
Evidence-Based Medicine
1
2012
254
0.360
Why?
Proton Pump Inhibitors
2
2011
83
0.360
Why?
Melanoma
1
2014
278
0.350
Why?
Education, Pharmacy
1
2012
144
0.330
Why?
Decision Making
1
2012
271
0.330
Why?
Clinical Competence
1
2012
403
0.320
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2014
997
0.290
Why?
Insurance Claim Review
1
2019
34
0.160
Why?
Drug Utilization
1
2019
79
0.150
Why?
Omeprazole
2
2011
17
0.150
Why?
Nonprescription Drugs
2
2011
35
0.150
Why?
Decision Support Techniques
1
2015
70
0.120
Why?
Carboplatin
1
2014
54
0.110
Why?
Indazoles
1
2014
46
0.110
Why?
Atrial Fibrillation
1
2015
188
0.100
Why?
Drug Information Services
1
2012
3
0.100
Why?
Anticoagulants
1
2015
254
0.100
Why?
Practice Guidelines as Topic
1
2015
473
0.100
Why?
Education, Distance
1
2012
41
0.100
Why?
Health Policy
1
2012
146
0.090
Why?
Drug Utilization Review
1
2011
23
0.090
Why?
State Government
1
2011
43
0.090
Why?
Cost Savings
1
2011
58
0.090
Why?
Organizational Policy
1
2011
39
0.090
Why?
Health Expenditures
1
2011
69
0.090
Why?
Humans
6
2019
50417
0.090
Why?
Communication
1
2012
256
0.090
Why?
Internet
1
2012
259
0.080
Why?
Insurance Coverage
1
2011
111
0.080
Why?
Curriculum
1
2012
393
0.080
Why?
Longitudinal Studies
1
2011
732
0.080
Why?
Databases, Factual
1
2011
676
0.070
Why?
Arkansas
2
2011
1974
0.070
Why?
Retrospective Studies
1
2019
6274
0.070
Why?
Proton Pumps
1
2006
2
0.060
Why?
Aged
1
2014
9738
0.040
Why?
Middle Aged
1
2014
12579
0.040
Why?
Adult
1
2014
13561
0.040
Why?
Male
1
2014
25867
0.030
Why?
Female
1
2014
27053
0.030
Why?
Risk Assessment
1
2015
1268
0.020
Why?
Cost-Benefit Analysis
1
2006
263
0.010
Why?
Johnson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description